Folgen
Ana Nordberg
Ana Nordberg
Associate Professor, Senior Lecturer, Faculty of Law, Lund University, Sweden
Bestätigte E-Mail-Adresse bei jur.lu.se - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Cutting edges and weaving threads in the gene editing (Я) evolution: reconciling scientific progress with legal, ethical, and social concerns
A Nordberg, T Minssen, S Holm, M Horst, K Mortensen, BL Møller
Journal of Law and the Biosciences 5 (1), 35-83, 2018
592018
Large expert-curated database for benchmarking document similarity detection in biomedical literature search
P Brown, AC Tan, MA El-Esawi, T Liehr, O Blanck, DP Gladue, ...
Database 2019, 2019
342019
Regulating germline editing in assisted reproductive technology: An EU cross‐disciplinary perspective
A Nordberg, T Minssen, O Feeney, I de Miguel Beriain, L Galvagni, ...
Bioethics 34 (1), 16-32, 2020
132020
Biobank and biomedical research: responsibilities of controllers and processors under the EU General Data Protection Regulation
A Nordberg
GDPR and Biobanking: Individual Rights, Public Interest and Research …, 2021
122021
A “Ray of Hope” for European Stem Cell Patents or “Out of the Smog into the Fog”? An Analysis of Recent European Case Law and How it Compares to the US
A Nordberg, T Minssen
IIC-International Review of Intellectual Property and Competition Law 47 …, 2016
122016
The Evolution of the CJEU's Case Law on Stem Cell Patents: Context, Outcome and Implications of Case C‑364/13 International Stem Cell Corporation.
T Minssen, A Nordberg
Published in Nordic Intellectual Property Law Review (NIR), 493-503, 2015
112015
The Impact of “Broccoli II” and “Tomatoes II” on European Patents in Conventional Breeding, GMOs, and Synthetic Biology: The Grand Finale of a Juicy Patents Tale?
T Minssen, A Nordberg
Biotechnology Law Report 34 (3), 81-98, 2015
102015
EU design law and 3D printing: finding the right balance in a new E-ecosystem
A Nordberg, J Schovsbo
3D Printing, Intellectual Property and Innovation–Insights from Law and …, 2016
82016
Trade secrets, big data and artificial intelligence innovation: a legal oxymoron?
A Nordberg
The Harmonization and Protection of Trade Secrets in the EU, 192-218, 2020
72020
CoViD-19 pandemic in Sweden: measures, policy approach and legal and ethical debates
A Nordberg, T Mattsson
Biolaw Journal-Rivista Di Biodiritto, 731-739, 2020
72020
Rules and Tools in the Battle Against Superbugs—A Call for Integrated Strategies and Enhanced International Collaboration to Promote Antimicrobial Drug Development
T Minssen, A Nordberg
Infectious Diseases in the New Millennium: Legal and Ethical Challenges, 111-136, 2020
52020
Patentability of methods of human enhancement
A Nordberg
Journal of Intellectual Property Law & Practice 10 (1), 19-28, 2015
42015
Balancing innovation,‘ordre public’and morality in human germline editing: A call for more nuanced approaches in patent law
D Matthews, T Minssen, A Nordberg
European Journal of Health Law 29 (3-5), 562-588, 2022
32022
Legal method and interpretation in international IP law: pluralism or systemic coherence
A Nordberg
Is Intellectual Property Pluralism Functional?, 96-127, 2019
32019
Defining Human Enhancement: towards a foundational conceptual tool for Enhancement Law
A Nordberg
Journal of Law, Information & Science 25 (3), 2017
3*2017
Governing, protecting, and regulating the future of genome editing: the significance of ELSPI perspectives
S Slokenberga, T Minssen, A Nordberg
Brill, 2023
22023
Genome editing in humans: A survey of law, regulation and governance principles
A Nordberg
Panel for the Future of Science and Technology (STOA), European Parliament, 2022
22022
The role of patents and licensing in the governance of human genome editing: a white paper
D Matthews, A Brown, E Gambini, T Minssen, A Nordberg, JS Sherkow, ...
Queen Mary Law Research Paper, 2021
22021
Sweden: Legal response to Covid-19
T Mattsson, A Nordberg, M Axmin
Oxford University Press, 2021
22021
Patentability of human enhancement: from ethical dilemmas to legal (un) certainty
A Nordberg
Intellectual Property Perspectives on the Regulation of New Technologies, 54-92, 2018
22018
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20